Focused on translating basic research discoveries into medical advances, more than 30 School of Medicine scientists are conducting their investigations in the new 225,000 square-foot UC Davis Genome and Biomedical Sciences Building. The researchers are from the following departments and divisions:

Research projects under way include studies in infectious diseases, cancer, nutrition, neuroscience, pulmonary medicine and cardiovascular biology. Many involve the study of genes, their protein products, cell membranes, ion channels and other key cellular and molecular components that hold promise as targets for new drugs and preventive therapies. By applying innovative molecular technologies such as microarrays, genomics and nanoscience, researchers are better understanding the interaction among multiple genes, complex cellular processes and pathogens.

The facility will also boost the developing biotechnology and high-technology industry in the Sacramento region, through education, commercialization of research discoveries, outreach and other activities. Ultimately, these programs will provide benefits in human health, agriculture and the environment and continue UC Davis' long tradition of work in the service of the region and the state.